LeMaitre Vascular Opens Office in Shanghai, China

BURLINGTON, Mass., Sept. 10, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has opened an office in Shanghai, China. To prepare for this initiative, the Company engaged its first Chinese employee in August 2014 to serve as the China Country Manager.

"The opening of our Shanghai office underscores LeMaitre Vascular's commitment to expanding in China. China is the third largest medical device market in the world and represents a dynamic growth opportunity for our products. Establishing a local presence should allow us to drive market launches and better serve our network of distributors as well as the vascular surgeons who use our products," said Peter Gebauer, President, International.

The Company expects to increase its CFDA approvals from one product currently to seven by the end of 2016. LeMaitre Vascular now has eight offices worldwide: Burlington, Frankfurt, Tokyo, Milan, Madrid, Melbourne, Toronto and Shanghai.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.

LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are based on the Company's current expectations and beliefs concerning future developments and their potential effects on the Company. There can be no assurance that future developments affecting the Company will be those that the Company has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company's control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties described in the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, and in its other filings from time to time filed with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of the Company's assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

CONTACT: LeMaitre Vascular, Inc. Peter Gebauer +49 (0)6196 659 230 pgebauer@lemaitre.com http://www.lemaitre.com

Source:LeMaitre Vascular, Inc.